ResMed, Inc. (NYSE:RMD)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

Recs

1
Player Avatar CelloSpice (81.17) Submitted: 3/4/2011 9:22:34 PM : Outperform Start Price: $30.71 RMD Score: +15.98

Because their strongest competitor, Respironics, has been bought by another company.

Featured Broker Partners


Advertisement